NLS merger partner Kadimastem secures Hong Kong patent for diabetes therapy
PositiveFinancial Markets
Kadimastem has successfully secured a patent in Hong Kong for its innovative diabetes therapy, marking a significant milestone in its efforts to combat the disease.
— via World Pulse Now AI Editorial System